Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, et al.
Blood (2018) Vol. 133, Iss. 9, pp. 893-901
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Complement in neurological disorders and emerging complement-targeted therapeutics
Marinos C. Dalakas, Harry Alexopoulos, Peter J. Spaeth
Nature Reviews Neurology (2020) Vol. 16, Iss. 11, pp. 601-617
Open Access | Times Cited: 261
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161
Mechanisms of haemolysis-induced kidney injury
Kristof Van Avondt, Erfan Nur, Sacha Zeerleder
Nature Reviews Nephrology (2019) Vol. 15, Iss. 11, pp. 671-692
Closed Access | Times Cited: 156
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D’Sa, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 14, pp. 1323-1334
Open Access | Times Cited: 156
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
Quentin A. Hill, Anita Hill, Sigbjørn Berentsen
Blood Advances (2019) Vol. 3, Iss. 12, pp. 1897-1906
Open Access | Times Cited: 98
How I treat cold agglutinin disease
Sigbjørn Berentsen
Blood (2021) Vol. 137, Iss. 10, pp. 1295-1303
Open Access | Times Cited: 93
Complementopathies and precision medicine
Eleni Gavriilaki, Robert A. Brodsky
Journal of Clinical Investigation (2020) Vol. 130, Iss. 5, pp. 2152-2163
Open Access | Times Cited: 90
Autoimmune hemolytic anemia: current knowledge and perspectives
Sylwia Sulimiera Michalak, Anna Olewicz‐Gawlik, Joanna Rupa‐Matysek, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Wilma Barcellini, Anna Zaninoni, Juri Alessandro Giannotta, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3859-3859
Open Access | Times Cited: 85
Antibody‐mediated complement activation in pathology and protection
Benjamin S. Goldberg, Margaret E. Ackerman
Immunology and Cell Biology (2020) Vol. 98, Iss. 4, pp. 305-317
Open Access | Times Cited: 84
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
Chiara Agostinis, Andrea Balduit, Alessandro Mangogna, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 80
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Is the COVID‐19 thrombotic catastrophe complement‐connected?
Edward M. Conway, Edward L.G. Pryzdial
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 11, pp. 2812-2822
Open Access | Times Cited: 65
Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics
Christopher J. Patriquin, Kevin H.M. Kuo
Transfusion Medicine Reviews (2019) Vol. 33, Iss. 4, pp. 256-265
Closed Access | Times Cited: 60
<p>Cold agglutinin disease: current challenges and future prospects</p>
Sigbjørn Berentsen, Alexander Röth, Ulla Randen, et al.
Journal of Blood Medicine (2019) Vol. Volume 10, pp. 93-103
Open Access | Times Cited: 57
Targeting the complement system in neuromyelitis optica spectrum disorder
Nithi Asavapanumas, Lukmanee Tradtrantip, A. S. Verkman
Expert Opinion on Biological Therapy (2021) Vol. 21, Iss. 8, pp. 1073-1086
Open Access | Times Cited: 50
Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond
Eleni Gavriilaki, Régis Peffault de Latour, Antonio M. Risitano
Blood (2021) Vol. 139, Iss. 25, pp. 3571-3582
Open Access | Times Cited: 48
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome
Marit Jalink, Sigbjørn Berentsen, Jorge J. Castillo, et al.
Blood (2021) Vol. 138, Iss. 20, pp. 2002-2005
Open Access | Times Cited: 42
The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration
Ying Chen, John Man Tak Chu, Raymond Chuen‐Chung Chang, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 337-337
Open Access | Times Cited: 34
Sutimlimab for Treatment of Cold Agglutinin Disease: Why, How And For Whom?
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Immunotherapy (2022) Vol. 14, Iss. 15, pp. 1191-1204
Open Access | Times Cited: 33
Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease
Lauren C. Bylsma, Anne Gulbech Ording, Adam Rosenthal, et al.
Blood Advances (2019) Vol. 3, Iss. 20, pp. 2980-2985
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top